News

Wyeth Pharmaceuticals has announced that the European Medicines Agency’s (EMEA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for the company’s pneumococcal conjugate

Nutricia North America has contacted customers to undertake the voluntary recall and replacement of one lot of the specialised infant formula product, Neocate. This recall involves a limited

Addex Pharmaceuticals has completed the enrollment in the phase IIb trial of ADX10059 as a monotherapy in patients with gastroesophageal reflux disease (GERD). ADX10059 is a first-in-class reflux

Onyx Pharmaceuticals has begun enrolling patients in a phase 1 study of ONX 0801, a novel alpha-folate receptor-mediated thymidylate synthase (TS) inhibitor, as a potential treatment for advanced

Merck & Co has entered into an exclusive agreement with CSL Biotherapies, a subsidiary of CSL Limited, to market and distribute CSL’s seasonal influenza vaccine Afluria in the

Raptor Pharmaceuticals Corp has revealed that its stockholders have approved the proposals to complete the proposed merger with TorreyPines Therapeutics. According to the company, the merger is expected

Flexible Stenting Solutions (FSS) has received Conditional Investigational Device Exemption (IDE) approval for its FlexStent Femoropopliteal Self Expanding Stent System. FSS is now authorized to begin its US

Sinochem Corp has entered into a Heads of Agreement with Nufarm in relation to a non-binding proposal for Sinochem to acquire all of the issued ordinary shares in

Sensitel has announced the release of VeriSupply secure document management subscription service. Designed as a business network, VeriSupply addresses the need for secure and discrete communication across in